Additionally, while the presence of traditional CSC markers (CD117, CD133, ALDH1) was variable across cell lines, SOX2 was consistently increased in 3D conditions, and elevated in recurrent cases of ovarian cancer, suggesting it may be a more reliable functional marker of CSC and disease recurrence. The gene discussed is ALDH1A1; the disease is ovarian carcinoma.